CAS 103060-53-3

Daptomicina

Descrizione:

Daptomicina è un antibiotico ciclico a lipopeptidi utilizzato principalmente per trattare infezioni causate da batteri Gram-positivi, inclusi Staphylococcus aureus resistente alla meticillina (MRSA). È prodotto mediante fermentazione del batterio Streptomyces roseosporus. Daptomicina presenta un meccanismo d'azione unico legandosi alla membrana cellulare batterica, portando a depolarizzazione, interruzione di processi cellulari essenziali e, infine, morte cellulare. Questo antibiotico è tipicamente somministrato per via endovenosa ed è noto per la sua efficacia contro infezioni complicate della pelle e delle strutture cutanee, così come batteriemia ed endocardite. Daptomicina è caratterizzato da un alto peso molecolare e una struttura complessa che include una coda di acido grasso, fondamentale per le sue proprietà di targeting della membrana. È generalmente ben tollerato, sebbene gli effetti collaterali potenziali possano includere dolore muscolare e livelli elevati di creatina fosfochinasi. A causa della sua azione specifica contro organismi Gram-positivi, Daptomicina è un'importante opzione terapeutica nella gestione delle infezioni batteriche resistenti.

Formula: C₇₂H₁₀₁N₁₇O₂₆

InChI: InChI=1/C72H101N17O26/c1-5-6-7-8-9-10-11-22-53(93)81-44(25-38-31-76-42-20-15-13-17-39(38)42)66(108)84-45(27-52(75)92)67(109)86-48(30-59(102)103)68(110)89-61-37(4)115-72(114)49(26-51(91)40-18-12-14-19-41(40)74)87-71(113)60(35(2)24-56(96)97)88-69(111)50(34-90)82-55(95)32-77-63(105)46(28-57(98)99)83-62(104)36(3)79-65(107)47(29-58(100)101)85-64(106)43(21-16-23-73)80-54(94)33-78-70(61)112/h12-15,17-20,31,35-37,43-50,60-61,76,90H,5-11,16,21-30,32-34,73-74H2,1-4H3,(H2,75,92)(H,77,105)(H,78,112)(H,79,107)(H,80,94)(H,81,93)(H,82,95)(H,83,104)(H,84,108)(H,85,106)(H,86,109)(H,87,113)(H,88,111)(H,89,110)(H,96,97)(H,98,99)(H,100,101)(H,102,103)/t35-,36-,37-,43+,44+,45+,46+,47+,48+,49+,50-,60+,61+/m1/s1

Sinonimi:

• (3S)-3-{[(2S)-4-amino-2-{[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino}-4-oxobutanoyl]amino}-4-{[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]amino}-4-oxobutanoic acid
• (3S)-3-{[(2S)-4-Amino-2-{[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino}-4-oxobutanoyl]amino}-4-{[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]amino}-4-oxobutans?ure
• acide (3S)-3-{[(2S)-4-amino-2-{[(2S)-2-(décanoylamino)-3-(1H-indol-3-yl)propanoyl]amino}-4-oxobutanoyl]amino}-4-{[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophényl)-2-oxoéthyl]-24-(3-aminopropyl)-15,21-bis(carboxyméthyl)-6-[(1R)-2-carboxy-1-méthyléthyl]-9-(hydroxyméthyl)-18,31-diméthyl-2,5,8,11,14,17,20,23,26,29-décaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohéntriacontan-30-yl]amino}-4-oxobutano?que
• Cidecin
• Deptomycin
• L-alpha-asparagine, N-(1-oxodecyl)-L-tryptophyl-L-asparaginyl-N-[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacont-30-yl]-
• Ly146032
• N-decanoyl-L-tryptophyl-L-asparaginyl-N-[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]-L-alpha-asparagine
• N-Decanoyl-L-tryptophyl-L-asparaginyl-N-[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]-L-alpha-asparagine
• Benzenebutanoic acid, N-(1-oxodecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α-glutamyl-α,2-diamino-γ-oxo-, (13→4)-lactone, (αS)-
• Cubicin
• Dapcin
• Daptomicina
• Daptomycine
• Daptomycinum
• Ly 146032

Daptomycin

CAS: 103060-53-3

Formula: C₇₂H₁₀₁N₁₇O₂₆

Purezza: >94.0%(HPLC)(N)

Colore e forma: White to Yellow to Orange powder to crystal

Peso molecolare: 1,620.69

Ref: 3B-D4229

Daptomycin

CAS: 103060-53-3

Formula: C₇₂H₁₀₁N₁₇O₂₆

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 1620.6706

Ref: IN-DA008RA9

Daptomycin

CAS: 103060-53-3

Formula: C₇₂H₁₀₁N₁₇O₂₆

Purezza: (HPLC) ≥ 92.0%

Colore e forma: Pale yellow to beige powder

Peso molecolare: 1620.7

Ref: 7W-GA1723

Daptomycin

CAS: 103060-53-3

Formula: C₇₂H₁₀₁N₁₇O₂₆

Colore e forma: Pale Yellow Solid

Peso molecolare: 1620.69

Ref: 4Z-PD-122001

Daptomycin

CAS: 103060-53-3

Daptomycin

Formula: C₇₂H₁₀₁N₁₇O₂₆

Purezza: By hplc: 96.29% (Typical Value in Batch COA)

Colore e forma: pale yellow crystalline powder

Peso molecolare: 1,620.67g/mol

Ref: 54-BID1023

Daptomycin

CAS: 103060-53-3

Daptomycin (LY146032) is a cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.

Formula: C₇₂H₁₀₁N₁₇O₂₆

Purezza: 99.61% - >99.99%

Colore e forma: White Powder

Peso molecolare: 1620.67

Ref: TM-T1665

Daptomycin

CAS: 103060-53-3

Applications Daptomycin is a Cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),

Formula: C₇₂H₁₀₁N₁₇O₂₆

Colore e forma: Light Yellow

Peso molecolare: 1620.67

Ref: TR-D193350

Daptomycin

CAS: 103060-53-3

Daptomycin is a cyclic lipopeptide that disrupts cell membrane potential and causes leakage from the cell. The antibacterial effects are limited to gram-positive bacteria since daptomycin can’t reach the outer membrane of gram-negative species. It is often used for infections cause by vancomycin-resistant enterococci and staphylococci.

Formula: C₇₂H₁₀₁N₁₇O₂₆

Purezza: Min. 93 Area-%

Colore e forma: Brown White Powder

Peso molecolare: 1,620.67 g/mol

Ref: 3D-AD15943

Daptomycin

CAS: 103060-53-3

Purezza: 98%

Peso molecolare: 1619.71

Ref: 10-F556521